Recruiting

Radiofrequency Ablation & Cement Augmentation

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT04751422

Conditions

Metastatic Malignant Neoplasm in the Spine

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Interventions

Electronic Health Record Review

Study Details

Brief summary:

This study collects data on the use of radiofrequency ablation and cement augmentation for the treatment of cancer that has spread to the spine (metastases to the spine). Radiofrequency ablation with cement augmentation is a useful approach for the treatment of secondary metastasis to the spine. Information collected in this study may help doctors to learn the effectiveness of this therapy, and may help to evaluate optimal technique, appropriate patient selection, and management of complications.

Conditions

Metastatic Malignant Neoplasm in the Spine

Study ID

NCT04751422

Start date

Nov 13, 2020

Status verified date

Apr, 2023

Completion date

Sep 30, 2023

Anticipated

Primary completion date

Sep 30, 2023

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Patients who underwent radiofrequency ablation with cement augmentation at the Department of Interventional Radiology at MD Anderson Cancer Center (MDACC) between 1/1/2017 and 9/26/2020

Exclusion Criteria:

  • None

Study Design

Enrollment

500 participants

Anticipated

Interventions and Outcome Measures

Arms

Observational (data collection)

Patients' medical data is collected retrospectively.

Interventions

Electronic Health Record Review

Medical data is collected

Primary outcome measure

  • Technical success [ Time Frame: Up to 3 years ]
  • Clinical success [ Time Frame: Up to 3 years ]
  • Complication rates [ Time Frame: Up to 3 years ]

Central Contacts and Locations

Locations

M D Anderson Cancer Center

Recruiting

Houston, Texas, United States, 77030

Contacts

Rahul A. Sheth

713-745-0652rasheth@mdanderson.org

Principal Investigator:

Rahul A. Sheth

More Information

Sponsor

M.D. Anderson Cancer Center

Last update posted

Apr 12, 2023

Last verified

Apr, 2023

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2023-04-12.